丨 2025年4月14日星期一丨 NO.1 博雅生物拟公开挂牌转让子公司80%股权 4月13日,博雅生物发布公告,称拟通过上海联合产权交易所挂牌转让江西博雅欣和制药有限公司(简称“博雅欣和”)80%股权,首次挂牌金额约为2.13亿元。博雅欣和于2014年成立,主营业务为抗感染类、糖尿病类、心脑血管类药品的研发、生产和销售,股权转让完成后,公司持有博雅欣和10.6869%股权,公司全资子公司江西...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.